Genprex Inc Financials
Financial Health Signals
Genprex Inc passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Genprex Inc generates $0.81 in operating cash flow (-$17.1M OCF vs -$21.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
This page shows Genprex Inc (GNPX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Genprex Inc generated $0 in revenue in fiscal year 2024.
Genprex Inc's EBITDA was -$20.4M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 34.3% from the prior year.
Genprex Inc reported -$21.1M in net income in fiscal year 2024. This represents an increase of 31.6% from the prior year.
Genprex Inc held $1.6M in cash against $0 in long-term debt as of fiscal year 2024.
Genprex Inc had 217,234 shares outstanding in fiscal year 2024. This represents a decrease of 85.4% from the prior year.
Genprex Inc invested $10.5M in research and development in fiscal year 2024. This represents a decrease of 40.2% from the prior year.
GNPX Income Statement
| Metric | Q3'25 | Q3'24 | Q4'23 | Q3'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | $0 | $0 | $0 | $0 |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $2.2M-20.4% | $2.8M | N/A | $4.6M+36.4% | $3.4M+7.2% | $3.2M+7.9% | $2.9M+43.5% | $2.0M |
| SG&A Expenses | $1.2M-26.4% | $1.6M | N/A | $3.2M-0.7% | $3.2M+6.0% | $3.0M+6.0% | $2.8M-13.1% | $3.3M |
| Operating Income | -$3.3M+22.6% | -$4.3M | N/A | -$7.8M-18.3% | -$6.6M-6.6% | -$6.2M-6.9% | -$5.8M-8.7% | -$5.3M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$3.8M+12.0% | -$4.3M | N/A | -$7.7M-18.8% | -$6.5M-6.2% | -$6.1M-6.6% | -$5.8M-8.6% | -$5.3M |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
GNPX Balance Sheet
| Metric | Q3'25 | Q3'24 | Q4'23 | Q3'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.6M-13.6% | $4.1M-61.3% | $10.7M-35.9% | $16.6M-33.7% | $25.1M-16.2% | $29.9M-13.4% | $34.6M-12.3% | $39.4M |
| Current Assets | $1.7M-17.4% | $2.1M-72.4% | $7.5M-41.4% | $12.9M-40.1% | $21.5M-18.4% | $26.3M-14.9% | $30.9M-13.5% | $35.7M |
| Cash & Equivalents | $1.1M-31.1% | $1.6M-76.2% | $6.7M-42.5% | $11.7M-44.1% | $21.0M-17.9% | $25.5M-15.1% | $30.1M-13.0% | $34.6M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | $0 | $0 | $0-100.0% | $35K0.0% | $35K | N/A | $32K |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $2.8M+11.6% | $2.5M-23.0% | $3.3M-25.0% | $4.3M+54.4% | $2.8M+14.4% | $2.5M+14.1% | $2.2M-9.7% | $2.4M |
| Current Liabilities | $2.6M+1.9% | $2.5M-23.0% | $3.3M-25.0% | $4.3M+54.4% | $2.8M+14.4% | $2.5M+14.1% | $2.2M-9.7% | $2.4M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $768K-52.6% | $1.6M-78.2% | $7.4M-39.7% | $12.3M-44.8% | $22.3M-19.0% | $27.5M-15.2% | $32.4M-12.5% | $37.0M |
| Retained Earnings | -$167.2M-8.0% | -$154.8M-15.8% | -$133.7M-4.6% | -$127.8M-24.2% | -$102.8M-6.8% | -$96.3M-6.8% | -$90.2M-6.8% | -$84.4M |
GNPX Cash Flow Statement
| Metric | Q3'25 | Q3'24 | Q4'23 | Q3'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$3.2M-2.9% | -$3.1M+37.6% | -$5.0M-4.8% | -$4.7M-4.1% | -$4.5M-0.5% | -$4.5M-0.9% | -$4.5M-10.0% | -$4.1M |
| Capital Expenditures | N/A | N/A | N/A | N/A | $0 | $0 | $0 | $0 |
| Free Cash Flow | N/A | N/A | N/A | N/A | -$4.5M-0.5% | -$4.5M-0.9% | -$4.5M-10.0% | -$4.1M |
| Investing Cash Flow | $0+100.0% | -$773K-7767.8% | -$10K+54.8% | -$22K-8.8% | -$20K-24.6% | -$16K+26.5% | -$22K-1086.7% | -$2K |
| Financing Cash Flow | $2.9M-26.1% | $4.0M+99570150.0% | $4-100.0% | $6.5M+139296.3% | $5K+166.4% | $2K | $0 | $0 |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
GNPX Financial Ratios
| Metric | Q3'25 | Q3'24 | Q4'23 | Q3'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -106.6%+3.8pp | -110.5% | N/A | -46.6%-20.5pp | -26.0%-5.5pp | -20.5%-3.8pp | -16.7%-3.2pp | -13.5% |
| Current Ratio | 0.67-0.2 | 0.83-1.5 | 2.31-0.6 | 2.96-4.7 | 7.64-3.1 | 10.71-3.6 | 14.35-0.6 | 14.97 |
| Debt-to-Equity | 3.64+2.1 | 1.55+1.1 | 0.44+0.1 | 0.35+0.2 | 0.13+0.0 | 0.09+0.0 | 0.070.0 | 0.06 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: The current ratio is below 1.0 (0.83), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Genprex Inc's annual revenue?
Genprex Inc (GNPX) reported $0 in total revenue for fiscal year 2024. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is Genprex Inc profitable?
No, Genprex Inc (GNPX) reported a net income of -$21.1M in fiscal year 2024.
What is Genprex Inc's EBITDA?
Genprex Inc (GNPX) had EBITDA of -$20.4M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Genprex Inc's operating cash flow?
Genprex Inc (GNPX) generated -$17.1M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Genprex Inc's total assets?
Genprex Inc (GNPX) had $4.1M in total assets as of fiscal year 2024, including both current and long-term assets.
How much does Genprex Inc spend on research and development?
Genprex Inc (GNPX) invested $10.5M in research and development during fiscal year 2024.
How many shares does Genprex Inc have outstanding?
Genprex Inc (GNPX) had 217,234 shares outstanding as of fiscal year 2024.
What is Genprex Inc's current ratio?
Genprex Inc (GNPX) had a current ratio of 0.83 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Genprex Inc's debt-to-equity ratio?
Genprex Inc (GNPX) had a debt-to-equity ratio of 1.55 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Genprex Inc's return on assets (ROA)?
Genprex Inc (GNPX) had a return on assets of -511.9% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Genprex Inc's cash runway?
Based on fiscal year 2024 data, Genprex Inc (GNPX) had $1.6M in cash against an annual operating cash burn of $17.1M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Genprex Inc's Piotroski F-Score?
Genprex Inc (GNPX) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Genprex Inc's earnings high quality?
Genprex Inc (GNPX) has an earnings quality ratio of 0.81x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.